59 related articles for article (PubMed ID: 13980982)
1. [Therapeutic application of an inhibitor of histidine-decarboxylase].
THIERS H; MOULIN G; ROUHANI A
Lyon Med; 1963 Mar; 209():689-94. PubMed ID: 13980982
[No Abstract] [Full Text] [Related]
2. [Considerations on the histidine-decarboxylase inhibitor (554 L) in the treatment of pruriginous disease].
Abry M
Lyon Med; 1967 Mar; 217(10):753-6. PubMed ID: 4387192
[No Abstract] [Full Text] [Related]
3. [Influence of histidine decarboxylase inhibitor 554 L (Hypostamine) on the behavior of certain indices of histamine and serotonin metabolism].
Czernielewski A; Pakszys W; Wranicz A; Matyjewska H
Przegl Dermatol; 1967; 54(1):17-22. PubMed ID: 4382888
[No Abstract] [Full Text] [Related]
4. [New derivatives with presumed histidine decarboxylase inhibitory action].
Giannini M; Fedi M
Boll Chim Farm; 1970 Jan; 109(1):39-47. PubMed ID: 4393826
[No Abstract] [Full Text] [Related]
5. Treatment of adjuvant arthritis in rats with the histidine decarboxylase inhibitor hypostamine.
Pelczarska A
J Pharm Pharmacol; 1969 Oct; 21(10):692-3. PubMed ID: 4390614
[No Abstract] [Full Text] [Related]
6. [Histidine decarboxylase inhibitors].
Kasztreiner E; Szilágyi G; Szakályné KJ; Huszti Z; Kürti M
Acta Pharm Hung; 1973 Jul; 43(3):121-5. PubMed ID: 4127039
[No Abstract] [Full Text] [Related]
7. Therapeutic effects of an antihistadine decarboxylase and antihistamine combination.
SCHULTZ J
Ann Allergy; 1951; 9(1):15-8. PubMed ID: 14800186
[No Abstract] [Full Text] [Related]
8. [Therapeutic application of a histidine decarboxylase inhibitor (554 L) in otorhinolaryngologic allergies].
Mounier-Kuhn P; Gaillard J; Fontvielle J
J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1968 May; 17(5):449-56. PubMed ID: 4386660
[No Abstract] [Full Text] [Related]
9. [Clinical study of the action of a histidine-decarboxylase inhibitor (L 554) on various allergic manifestations].
CASTELAIN PY
Mars Med; 1963; 100():121-9. PubMed ID: 14019175
[No Abstract] [Full Text] [Related]
10. Clinical observations on the effectiveness of a combination of an antihistadine decarboxylase and an antihistamine; preliminary report.
CHUNN L
Ann Allergy; 1951; 9(1):11-4; passim. PubMed ID: 14800185
[No Abstract] [Full Text] [Related]
11. [Biological study of the effects of a histidine decarboxylase inhibitor (L 554) on histidine metabolism].
Cotte J; Collombel C; Carron R
Pediatrie; 1966; 21(7):841-3. PubMed ID: 4382608
[No Abstract] [Full Text] [Related]
12. [Action of an inhibitor of histidine decarboxylase on the liberation and reconstitution of cutaneous histamine in rats].
Grilliat JP; Laurent J; Noirel B; Arnould P
Rev Fr Allergol; 1966; 6(2):84-92. PubMed ID: 4161301
[No Abstract] [Full Text] [Related]
13. Histamine excretion and dermographism in urticaria pigmentosa before and after administration of a specific histidine-decarboxylase inhibitor.
Greaves MW
Br J Dermatol; 1971 Nov; 85(5):467-70. PubMed ID: 4108905
[No Abstract] [Full Text] [Related]
14. [Preliminary clinical trials of a new histidine-decarboxylase inhibitor in the therapy of prurigo].
Rossi A; De Luca M
Arch Anat Microsc Morphol Exp; 1970; 59(2):201-4. PubMed ID: 4194817
[No Abstract] [Full Text] [Related]
15. [In vivo anihistidine-decarboxylasic activity of 2-methyl-6,7-methylendioxy-8-methoxy-1-(4', 5', 6',-triothoxy-7-aminophthalidyl)-1,2,3,4 tetrahydroisoquinoline (tritoqualine)].
Carpi C; Maggi GC
Boll Soc Ital Biol Sper; 1968 Mar; 44(6):543-6. PubMed ID: 5674876
[No Abstract] [Full Text] [Related]
16. Apomorphine-induced turning behavior in 6-hydroxydopamine lesioned rats is increased by histidine and decreased by histidine decarboxylase, histamine H1 and H2 receptor antagonists, and an H3 receptor agonist.
Liu CQ; Hu DN; Liu FX; Chen Z; Luo JH
Pharmacol Biochem Behav; 2008 Sep; 90(3):325-30. PubMed ID: 18452981
[TBL] [Abstract][Full Text] [Related]
17. [On the occurrence of histidine decarboxylase in Salmonella strains of various serotypes].
Scheibner G
Z Gesamte Hyg; 1968 Mar; 14(3):204-6. PubMed ID: 5734011
[No Abstract] [Full Text] [Related]
18. Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors: a study in histidine decarboxylase gene knockout mice.
Yoshida A; Mobarakeh JI; Sakurai E; Sakurada S; Orito T; Kuramasu A; Kato M; Yanai K
Eur J Pharmacol; 2005 Oct; 522(1-3):55-62. PubMed ID: 16212954
[TBL] [Abstract][Full Text] [Related]
19. Role of histaminergic neurons in development of epileptic seizures in EL mice.
Yawata I; Tanaka K; Nakagawa Y; Watanabe Y; Murashima YL; Nakano K
Brain Res Mol Brain Res; 2004 Dec; 132(1):13-7. PubMed ID: 15548424
[TBL] [Abstract][Full Text] [Related]
20. [Preparative isolation of crystalline histidine decarboxylase from Micrococcus sp. n].
Prozorovskiĭ VN; Tartakovskiĭ SA; Alekseeva AE; Mardashev SR; Nikolaev AIa
Biokhimiia; 1970; 35(4):759-62. PubMed ID: 5498657
[No Abstract] [Full Text] [Related]
[Next] [New Search]
